Clinical Trials Logo

Asthma Copd clinical trials

View clinical trials related to Asthma Copd.

Filter by:
  • None
  • Page 1

NCT ID: NCT06417931 Completed - Asthma COPD Clinical Trials

Medication Adherence and Use of Inhaler Devices in Patients With Asthma or COPD

Start date: October 4, 2023
Phase: N/A
Study type: Interventional

This study aims to evaluate the impact of a pharmacist-led intervention programme on medication adherence and use of inhaler devices on clinical outcomes of patients with asthma and COPD attending a tertiary health facility in Nigeria.

NCT ID: NCT06099145 Recruiting - Asthma COPD Clinical Trials

Clinical and Medico-economic Validation of the HEPHAI Solution.

VAL-HEPHAI
Start date: September 19, 2023
Phase: N/A
Study type: Interventional

In a context where the use of inhalation devices for respiratory medications is associated with a high frequency of critical errors, our primary hypothesis is that the use of the HEPHAÏ solution reduces this frequency compared to standard care. The objective of this clinical study is to evaluate the performance of the HEPHAÏ solution as a tool for improving the administration of inhaled treatments in patients undergoing pulmonary care for asthma and/or COPD, who are receiving treatment with Innovair® or Trimbow®. These two inhalers were chosen for reasons of feasibility and compatibility with the version of the HEPHAÏ software provided as part of the clinical investigation

NCT ID: NCT06039943 Recruiting - Asthma COPD Clinical Trials

Relationship Between Acoustic Breath Sounds and Spirometry

Start date: March 13, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to assess whether wheeze as assessed by a commercially available wheeze monitor is comparable to lung function as measured during a spirometry test. The main questions it aims to answer are whether measures of airflow obstruction (FEV1, FEV1/FVC, PEF) correlate with wheeze score (Tw/Ttot%). Participants consenting to take part will undergo wheeze measurement prior to and during a spirometry test and will be asked to complete a series of symptom questionnaires.

NCT ID: NCT05764343 Completed - Clinical trials for Bronchiectasis Adult

The Effect of Immediate Smoking Cessation Interventions for Smokers With Chronic Airway Diseases

Start date: November 15, 2022
Phase: N/A
Study type: Interventional

Smoking cessation support is provided by smoking cessation outpatient clinics in our country. Smokers with chronic airway diseases can also apply to these services by making an appointment from quit lines. Quit rates of that group patients were found to be similar to the general population. In novel smoking cessation support approaches immediate cessation support is reported to be more effective than routine practice. The sample in these studies consists of individuals who applied for lung health screening programmes. There is no study in the literature examining the effect of this immediate support on patients with chronic airway diseases' quit success. Our aim with this study is to examine impact of immediate cessation support by getting an appointment to the same cessation clinic instantly on our sample's cessation success.

NCT ID: NCT05299385 Recruiting - Lung Cancer Clinical Trials

The Study for Evaluating the Clinical Effectiveness and Safety of Respiratory Rehabilitation Software 'Redpill Breath'(COPD, Asthma, Lung Cancer, Etc.)

Start date: January 13, 2022
Phase: Phase 3
Study type: Interventional

The purpose of the study is to prove the clinical superiority of respiratory rehabilitation software "Redpill Breath" and evaluate the clinical improvement effect by 6-minute walk test of the software, compared to the manual rehabilitation management for those who need respiratory rehabilitation(COPD, Asthma, Lung Cancer, etc.)

NCT ID: NCT05006521 Active, not recruiting - Asthma COPD Clinical Trials

Single and Multiple Ascending Dose Study of KN-002

KN-002
Start date: July 30, 2021
Phase: Phase 1
Study type: Interventional

This is a Phase 1, randomized, double-blinded, placebo controlled study. The study consists of 4 parts: Part 1 is a single ascending dose (SAD) study in healthy volunteers; Part 2 is a multiple ascending dose (MAD) study in subjects with stable, mild asthma; Part 3 is a repeat dose in patients with moderate to severe asthma and Part 4 is a repeat dose in patients with COPD.

NCT ID: NCT04341701 Active, not recruiting - Asthma Copd Clinical Trials

Phenotype Identification Based on Multimodal MRI Analysis of Patients With Bronchial Obstructive Diseases

PIMABOD
Start date: August 5, 2021
Phase: N/A
Study type: Interventional

The hypothesis is that pulmonary and cardiac proton MRI allows phenotyping of patients with bronchial obstruction by cluster analysis based on quantitative multimodal imaging of bronchi, pulmonary vessels, pulmonary parenchyma, right and left ventricular function, myocardial fibrosis and pulmonary arterial pressure. Such imaging will also offer the advantage of being non-irradiating and without contrast products, which will ultimately allow CT to be replaced by MRI in the follow-up of bronchial obstructive patients, thus avoiding the risks associated with repeated exposure to ionizing radiation.

NCT ID: NCT04233190 Recruiting - Asthma Copd Clinical Trials

A Multicenter, Randomized, Parallel, Two-Period, Non-Inferiority Study of EurofarmavsAlenia in Asthma and COPD Treatment

ESPIRE
Start date: April 19, 2023
Phase: Phase 3
Study type: Interventional

A phase III study, multicenter, randomized, parallel, open, two-period, comparative non-inferiority of Eurofarma versus Alenia® in the treatment of moderate to severe persistent asthma with and without obstructive pulmonary disease (COPD). ⚠️study will only be conducted in research centers in Brazil (please do not send e-mail if your center is outside brazil).

NCT ID: NCT03858686 Completed - Asthma, COPD Clinical Trials

The Effect of FP-025, on Allergen-induced Airway Responses in Mild Eosinophilic House Dust Mite (HDM)-Allergic Asthma.

Start date: July 2, 2018
Phase: Phase 2
Study type: Interventional

This study is a Phase IIa, randomized, placebo-controlled, double-blind, 2-way crossover, 2-center (conducted in EU; The Netherlands) study in male and female subjects with stable, mild HDM-allergic asthma.